Celldex Therapeutics | CLDX - Dochód Netto





Dochód Netto Zmiana Data
AbbVie USD 3.61B 2.92B 2026-06
Agenus USD 39.17M 49.8M 2026-03
Amgen USD 2.38B 556M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Celldex Therapeutics USD -73.5M 5.18M 2026-06
Glaxosmithkline GBP 1.74B 890.94M 2026-03
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Northwest Biotherapeutics USD -3.4M 23.78M 2026-03
Pfizer USD -248M 2.94B 2026-06
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Roche Holding CHF 6.87B 1.4B 2026-06